Onyx Biotec IPO GMP grey market premium, review, Subscription, allotment, listing estimate @
Chanakyanipothi.com, a legacy of 31 Years.
India`s Oldest Investment & IPO website.
Most Trusted by Investors across India.
Table of Contents
Onyx Biotec listing Review
Will give detailed review on listing of this IPO
Onyx Biotec IPO allotment Link
For latest GMP, Click
Subscription status of Onyx Biotec IPO
Onyx Biotec Limited IPO Price Rs. 61 Lot 2000 shares, Rs. 29.34 Crore |
||||
QIB | NII x | RII x | Total x | Applications |
32.49 | 602.86 | 118.26 | 198.00 | 103,947 (129.93x) |
Amount wise bids recd. Rs. ? Crore | ||||
Note: |
What is the business of Onyx Biotec?
Onyx Biotec IPO Details |
|
IPO opens on | 13 November 2024 |
IPO closes on | 18 November 2024 |
Issue Type | Book Built Issue IPO |
Issue Size | 4810,000 Shares / Rs 29.34 Crore |
* Fresh Issue | 4810,000 Shares / Rs 29.34 Crore |
* Offer for Sale – | – shares / Rs. – crore |
Market Maker Portion | ? Shares |
Net offer to Public | Shares/ Rs. Crore |
Face Value per share | Rs. 10 |
Price Band | Rs. 61 |
Employee discount | Rs. 0 per share |
Retail Lot Size | 2000 Shares |
Listing will at | NSE SME |
Shares offered in IPO |
||
Shares | Rs. (Crore) | |
QIB (50%) | ? | ? |
NII (15%) | ? | ? |
RII (35%) | ? | ? |
Total Shares | ? | ? |
Retail portion will be oversubscribed by |
? | |
Forms | ||
How much Shares to Apply in this IPO? | ||
Min Retail Application | 2000 Shares | Rs.122000 |
Min HNI Application | 4000 Shares | Rs.244000 |
Who are the Promoters of Onyx Biotec?
The Promoters of the company are Kantilal Jethva and Bhavin Jethwa.
What are the Objects of Onyx Biotec IPO?
The Offer comprises of fresh issue of shares
The Company proposes to utilize the Net Proceeds from the Issue towards the following objects:
1. Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use;
2. Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections;
3. Prepayment or repayment of all or a portion of certain loans availed by the Company; and
4. General Corporate Purposes.
Tentative timetable |
|
IPO opens on | 13 November 2024 |
IPO Closes on | 18 November 2024 |
IPO Allotment on | 19 November 2024 |
Refund Initiation | 20 November 2024 |
Credit of Shares | 20 November 2024 |
Listing on | 21 November 2024 |
Registered Office of the Company Bir Plassi Near Sainimajraropar, Nalagarh Road, District Solan – 174 101, Himachal Pradesh, India |
Who is the Lead Manager of this IPO? Horizon Management Private Limited |
Who is the Registrar to IPO? MAS SERVICES LIMITED |
Onyx Biotec IPO GMP grey market premium, review, Subscription, allotment, listing estimate
Onyx Biotec IPO Financial & Analytical Ratios |
||||
Year | Total Income |
Net Profit |
EPS | RoNW |
Rs.in Crore | Rs.in Crore | Rs. | % | |
2021-22 | 44.98 | 3.35 | 2.84 | |
2022-23 | 39.62 | 1.84 | 1.56 | |
2023-24 | 53.87 | 3.30 | 2.54 | |
Book Value of the Share on 31.03.2024 |
Rs | 18.67 | ||
BV of the Share at cap price after IPO |
Rs. | |||
Offer Price/upper band | Rs. | 61 |
IPO
|
|
Price/EPS of 23-24 | 24.01 |
Price/BV Ratio | 3.26 |
Price/BV after IPO |
How Onyx Biotec IPO compares with the Peers?
There is no peer group listed company.
As on date of DRHP | FV | Total | PE |
Rs. | Income | Ratio of | |
Rs. In Crore | |||
Onyx Biotec | 10 | ||
Suven Pharmachem | 1 | 1051 | 83.92 |
JB Chemicals | 1 | 3484 | 53.63 |
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Onyx Biotec IPO Review
Onyx Pharmaceuticals: A Leading Supplier of Sterile Pharmaceutical Products
Onyx Pharmaceuticals has earned a strong reputation in the healthcare sector, specializing in the production and supply of sterile pharmaceutical products. Over the years, the company has become a prominent and trusted supplier to major pharmaceutical corporations, including some of the top-tier companies across India.
IPO Details: Size and Market Outlook
The IPO size is Rs. 29.34 crore, offering 4,810,000 shares. While the size is relatively modest compared to recent IPOs, the company’s strong business model and consistent growth trajectory make the IPO highly attractive. Given the company’s robust performance and promising outlook, the offering has the strong potential to be oversubscribed.
Strong Financial Performance and Reasonable Valuation
Onyx Pharmaceuticals has demonstrated impressive and consistent growth in both topline and bottomline over the past three years, further solidifying its position in the market. With its strong financial track record and solid fundamentals, the shares are offered at a reasonable valuation, making it an appealing investment opportunity.
A Worthwhile Investment Opportunity
Even in the absence of a grey market premium, the Onyx Pharmaceuticals IPO presents a compelling case for investment. With strong growth prospects and a proven business model, this IPO is a solid opportunity for investors looking to tap into the growing pharmaceutical sector.
+ from fundamental angle: Must Apply
+ from grey market angle: Not attractive
Quicklinks
Onyx Biotec IPO GMP today allotment, review?
Onyx Biotec IPO GMP grey market premium
Onyx Biotec IPO FAQs
What is Onyx Biotec IPO?
This is a SME IPO of 4810000 equity shares of the face value of Rs. 10 aggregating up to Rs.29.34 Crores. The issue is priced at Rs.61 per share. The minimum order quantity is 2000 Shares.
When will Onyx Biotec IPO subscription open?
Onyx Biotec IPO opens on November 13, 2024, and closes on November 18, 2024.
What is the lot size of Onyx Biotec IPO?
Onyx Biotec IPO lot size is 2000 Shares, and the minimum amount required is Rs.122000
How to apply for Onyx Biotec IPO?
You can apply in Onyx Biotec IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
When is Onyx Biotec IPO allotment?
The finalization of Basis of Allotment for Onyx Biotec IPO will be done on November 19, 2024, and the allotted shares will be credited to your demat account by November 20, 2024.
When is Onyx Biotec IPO listing date?
Onyx Biotec IPO listing date is November 21, 2024.